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Introduction: 
The COVID-19 pandemic is having a profound impact on the world. As of May 18, 2020, there 
were 4,889,287 confirmed cases and 322,683 deaths globally[1]. The healthcare system is 
wrestling with a virus that threatens to overwhelm hospital capacity, while simultaneously 
confronting an unprecedented reduction in elective and non-essential care[2, 3]. A survey by the 
American Cancer Society showed that 50% of cancer patients and survivors reported some 
impact to their healthcare due to the COVID-19 epidemic[4] 
A recent survey was conducted by Forbes et al to evaluate the changes in GI and endoscopy 
practices in North America[5].  However, the impact of this epidemic on endoscopy units 
globally has not been studied. 
Methods: 
A web-based survey was developed by leaders of the World Endoscopy Organization (WEO). 
The questionnaire included 16 questions focused on the endoscopy units’ baseline volumes, the 
impact on procedure numbers during the peak of the COVID 19 epidemic, the use of Personal 
Protection Equipment (PPE) and if any endoscopy personnel contracted the infection. The  
survey was sent out on April 23, 2020 and responses were collected through May 12, 2020. The 
detailed questionnaire is provided in supporting document 1. All participants provided informed 
consent for the collection, handling, and storage of data. For this survey, Institutional Review 
Board exemption was provided by Swedish Medical Center, Seattle, WA.  
 
Statistical Analysis: 
Descriptive statistics were used to analyze responses. Continuous variables were reported as 
mean ± standard deviation or median (IQR), and categorical variables were summarized as 
frequency and percentage. Data were compared across continents and tertiles of pre-COVID 
volume using one-way ANOVA for continuous and chi-square for categorical variables.  All 
statistical analyses were performed using SAS 9.4 (Cary, NC).  
 
 
Results: 
From April 23 to May 12, 2020, a total of 252 endoscopy units globally responded to the survey 
performing a total of 2,069,447 endoscopic procedures in a year (at baseline). These 
endoscopy units represent a total of 2810 endoscopists, 3024 endoscopy nurses and 1334 
endoscopy technicians from 55 countries across 6 continents. The median number of 
endoscopic procedures performed annually among the endoscopy units was 5000 (IQR: 2000, 
9000), number of endoscopists in each center was 7 (IQR: 3, 13), number of endoscopy nurses 
was 6.5 (IQR : 3, 15), and number of technicians was 3 (1, 6).  
Impact of COVID -19 on Baseline Endoscopy Volumes: 
Compared to baseline, during the COVID -19 pandemic, endoscopy units reported, on average, 
an 83% reduction in total endoscopy volumes.  There was an 82% reduction in upper 
  
endoscopy procedures (EGD/ EUS/ ERCP) and an 85% reduction in lower endoscopy (flexible 
sigmoidoscopy/ colonoscopy) (Figure1b).  
These reductions in endoscopy volumes were consistent across all continents except for 
Oceania (Australia and New Zealand) that continued to perform approximately 41% of 
procedures compared to baseline (p =0.008 for comparison with other continents) (Figure 1a).  
Use of PPE: 
For upper endoscopy, the use of PPE was as follows: N95/PAPR in 78.6% of cases, surgical 
masks 65.9%, gloves 96%, gown 92.1%, and goggles 83.7%. The use of N95 by continent are 
shown in figure 1c and figure 1d (grouped by baseline case volume).  Endotracheal intubation 
was used in approximately 12% of the upper procedures. 
With regard to PPE use for lower endoscopy: N95/PAPR in 68.7% of cases, surgical masks 
77.2%, gloves 96%, gowns 91.3%, and goggles in 77%.  (Supplementary Table 1: 
Characteristics of Endoscopy Units that participated in the survey based on Continents).  Use of 
N95/PAPR masks was significantly higher for upper compared to lower endoscopy (p<0.001). 
Results of PPE use stratified by baseline procedure volumes is shown in supplementary table 2 
with no significant difference in PPE usage noted among centers based on these volumes 
(Characteristics of participating endoscopy units based on baseline total number of procedures 
performed in tertiles).  
SARS-CoV-2 infection among endoscopy personnel: 
A total of 34 endoscopy units (13.5%) reported SARS-CoV-2 positive cases among their 
endoscopy personnel with 48.6% of these cases in Europe. Only 7.9% of the positive cases 
required hospitalization. Endoscopy units that performed a higher procedure volume at baseline 
reported a higher rate of SARS-CoV-2 infection: 27.1% in third tertile versus 13.5 % in first 
tertile (p<0.001) 
In addition to the analyses above, we assessed the geographic distribution of our sample to 
display survey data using ArcGIS Pro 2.5 (Esri, Redlands, CA) (Figure 1e). 
 
Discussion: 
This is the first study to assess the impact of the COVID 19 pandemic on endoscopy practices 
around the world. We surveyed endoscopy units representing 55 countries across 6 continents.  
The most important finding of the present study was the massive cutback of endoscopy 
procedures by 83% (compared to baseline procedures) across the world during the pandemic 
period. This type of approach both by the health/ hospital authorities and the endoscopists has 
several un-doubtable reasons: to save resources for COVID-19 patients (medical and nurse 
staff, hospital beds, intensive care units, economical resources, PPE), and to reduce the risk of 
infection (staff and patients). An interesting finding was the relatively higher volume of upper 
and lower endoscopies performed in Oceania during the COVID period, possibly a reflection of 
the impact of COVID 19 in these countries (only 1500 cases by May 25, 2020).  
In addition, our survey showed that only 34 (13.5%) of the participating centers reported SARS-
CoV-2 positive cases amongst their endoscopy staff suggesting that the risk of transmission of 
  
this infection among endoscopy personnel while using appropriate PPE may be low. This finding 
is in agreement with data from an Italian study showing a low risk of infection[7] as well. 
Although several GI societies have suggested that all endoscopic procedures should be 
considered aerosol generating procedures (AGP), our survey showed that the use of N95 
masks was significantly higher during upper as compared to lower endoscopy procedures.  This 
could be due to the perception of an increased risk of transmission via aerosolized droplets 
perceived to be higher during upper endoscopy.  
In conclusion, this is the first study to evaluate the impact of COVID -19 pandemic on 252 
endoscopy units worldwide across 6 continents encompassing 55 countries. A substantial 
reduction (>80%) in endoscopy procedures has been noted globally; future research can 
evaluate potential clinical impacts of this reduction. In general, the proportion of endoscopy units 
reporting infected personnel has been low.  
 
Figure legend:  
Figure 1a: Histogram showing the distribution of type of endoscopy which were performed 
before and at the beginning of COVID-19 pandemic by each continent.  
Figure1b: Histogram showing the distribution of type of endoscopy which were performed before 
and at the beginning of COVID-19 pandemic based on baseline volume. 
Figure 1c: Histogram showing the use of N95 during upper endoscopy based on continent. 
Figure 1d: Histogram showing the use of N95 during upper endoscopy based on baseline 
volume of procedures. 
Figure 1e: shows the number of endoscopy units’ respondents according to geographic location. 
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Table 1: Characteristics of Endoscopy Units that participated in the survey based on Continents 
 
 
  
 
 
 
Total CONTINENT      P-Value 
n = 252 AFRICA 
n = 23 
ASIA 
n = 138 
EUROPE 
n = 35 
NORTHAM 
n = 32 
OCEANIA 
n = 5 
SOUTHAM 
n = 19 
Volume of procedures performed in a ye
ar 
     Mean ± SD 
     Median (IQR) 
     Sum 
  
8212.1 ± 15133.2 
5000.0 (2000.0, 9000.
0) 
2069447 
  
2619.6 ± 1792.5 
2400.0 (1000.0, 3000.
0) 
60250.0 
  
9623.0 ± 19372.2 
5000.0 (1600.0, 9
715.0) 
1327971 
  
9380.0 ± 7492.
4 
9000.0 (5000.0
, 12000.0) 
328300.0 
  
6523.4 ± 6985.
4 
4500.0 (2000.0
, 8500.0) 
208750.0 
  
5340.0 ± 1789.7 
5000.0 (4500.0, 6
700.0) 
26700.0 
  
6182.9 ± 8535
.3 
4000.0 (901.0
, 6000.0) 
117476.0 
     < 0.001 K 
Endoscopy volume during Feb-May2020 
     Mean ± SD 
     Median (IQR) 
     Sum 
  
1833.7 ± 8166.5 
500.0 (125.0, 1500.0) 
462086.7 
  
477.5 ± 532.3 
300.0 (120.0, 600.0) 
10982.5 
  
2545.0 ± 10946.8 
500.0 (100.0, 174
8.7) 
351212.1 
  
1518.6 ± 1417.
6 
1000.0 (400.0, 
2040.0) 
53150.0 
  
699.3 ± 1015.0 
300.0 (150.0, 7
50.0) 
22376.5 
  
2365.2 ± 1835.9 
1875.0 (1125.0, 3
000.0) 
11826.0 
  
660.0 ± 1008.
3 
250.0 (70.0, 6
00.0) 
12539.6 
       0.001 K 
Total no. of endoscopists in unit 
     Mean ± SD 
     Median (IQR) 
  
11.0 ± 14.4 
7.0 (3.0, 13.0) 
  
10.4 ± 9.9 
6.0 (4.0, 12.0) 
  
11.0 ± 16.9 
5.0 (3.0, 12.0) 
  
9.7 ± 7.4 
8.0 (5.0, 12.0) 
  
11.3 ± 13.0 
7.0 (4.0, 14.0) 
  
14.4 ± 5.5 
14.0 (12.0, 15.0) 
  
12.1 ± 13.8 
8.0 (4.0, 16.0) 
       0.187 K 
Total no/ of endoscopy nurses in unit 
     Mean ± SD 
     Median (IQR) 
  
11.8 ± 14.8 
6.5 (3.0, 15.0) 
  
7.3 ± 6.0 
6.0 (4.0, 8.0) 
  
10.3 ± 13.6 
5.0 (3.0, 15.0) 
  
17.5 ± 19.0 
12.0 (7.0, 18.0) 
  
16.1 ± 18.6 
10.0 (5.5, 15.5) 
  
27.8 ± 10.7 
27.0 (25.0, 35.0) 
  
6.1 ± 6.8 
4.0 (2.0, 7.0) 
     < 0.001 K 
Total no. of endoscopy technicians in you
r unit 
     Mean ± SD 
     Median (IQR) 
  
5.2 ± 7.8 
3.0 (1.0, 6.0) 
  
2.8 ± 2.8 
2.0 (1.0, 4.0) 
  
4.2 ± 5.2 
3.0 (2.0, 5.0) 
  
7.7 ± 13.6 
4.0 (0.0, 8.0) 
  
6.0 ± 5.9 
5.5 (2.5, 8.0) 
  
2.2 ± 2.2 
3.0 (0.0, 3.0) 
  
10.2 ± 12.7 
7.0 (1.0, 10.0) 
       0.069 K 
% of procedures performed in your cente
r since COVID infection in your region co
mpared to baseline 
     Mean ± SD 
     Median (IQR) 
  
17.1 ± 17.6 
10.0 (5.0, 20.0) 
  
20.2 ± 21.2 
10.0 (5.0, 30.0) 
  
16.3 ± 17.3 
10.0 (5.0, 20.0) 
  
20.0 ± 16.9 
15.0 (5.0, 30.0) 
  
13.3 ± 15.0 
10.0 (5.0, 17.5) 
  
41.6 ± 25.9 
25.0 (25.0, 60.0) 
  
13.7 ± 13.4 
10.0 (5.0, 15.
0) 
       0.066 K 
% of EGD/EUS/ERCP procedures during C
OVID compared to baseline 
     Mean ± SD 
     Median (IQR) 
  
18.8 ± 20.7 
10.0 (5.0, 25.0) 
  
17.1 ± 23.1 
5.0 (2.0, 20.0) 
  
17.7 ± 20.8 
10.0 (5.0, 20.0) 
  
27.1 ± 22.2 
20.0 (5.0, 50.0) 
  
14.1 ± 15.4 
10.0 (5.0, 17.5) 
  
44.4 ± 26.9 
30.0 (25.0, 70.0) 
  
13.9 ± 11.8 
10.0 (3.0, 25.
0) 
       0.008 K 
%  of colonoscopy/sigmoidoscopy proced
ures performed during COVID compared 
to baseline 
  
15.2 ± 18.9 
10.0 (3.0, 20.0) 
  
16.6 ± 21.4 
10.0 (2.0, 25.0) 
  
14.2 ± 18.7 
8.5 (2.0, 20.0) 
  
19.8 ± 20.1 
10.0 (5.0, 30.0) 
  
10.7 ± 13.8 
5.0 (2.0, 10.0) 
  
44.0 ± 29.0 
30.0 (25.0, 70.0) 
  
12.2 ± 13.6 
10.0 (3.0, 10.
0) 
       0.016 K 
Table 1: Characteristics of Endoscopy Units that participated in the survey based on Continents 
 
 
     Mean ± SD 
     Median (IQR) 
         
   
Total 
 
CONTINENT 
 
p-value 
 n = 252 AFRICA 
n = 23 
ASIA 
n = 138 
EUROPE 
n = 35 
NORTHAM 
n = 32 
OCEANIA 
n = 5 
SOUTHAM 
n = 19 
 
PPE for colonoscopy/sigmoidoscopy         
Face Mask/surgical mask 182 (72.2%) 18 (78.3%) 98 (71.0%) 22 (62.9%) 26 (81.3%) 5 (100.0%) 13 (68.4%)        0.422 
PAPR 36 (14.3%) 3 (13.0%) 21 (15.2%) 4 (11.4%) 6 (18.8%) 1 (20.0%) 1 (5.3%)        0.781 
N95 167 (66.3%) 11 (47.8%) 95 (68.8%) 21 (60.0%) 23 (71.9%) 1 (20.0%) 16 (84.2%)        0.031 
None 5 (2.0%) 3 (13.0%) 2 (1.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)        0.055 
Gloves 242 (96.0%) 20 (87.0%) 135 (97.8%) 31 (88.6%) 32 (100.0%) 5 (100.0%) 19 (100.0%)        0.028 
Gown 230 (91.3%) 19 (82.6%) 128 (92.8%) 29 (82.9%) 31 (96.9%) 5 (100.0%) 18 (94.7%)        0.202 
Goggles 194 (77.0%) 12 (52.2%) 108 (78.3%) 28 (80.0%) 25 (78.1%) 4 (80.0%) 17 (89.5%)        0.099 
How often used? ( in %) 
     Mean ± SD 
     Median (IQR) 
      
  
92.9 ± 20.7 
100.0 (100.0, 100.0) 
 
  
96.4 ± 5.5 
100.0 (90.0, 100.0) 
 
  
90.7 ± 24.3 
100.0 (95.0, 100.0
) 
 
  
90.2 ± 25.0 
100.0 (100.0, 1
00.0) 
 
  
98.7 ± 3.1 
100.0 (100.0, 1
00.0) 
 
  
100.0 ± 0.0 
100.0 (100.0, 100
.0) 
 
  
98.4 ± 5.1 
100.0 (100.0, 
100.0) 
 
       
 0.443 K 
PPE for EGD/EUS/ERCP         
Face Mask/surgical mask 166 (65.9%) 16 (69.6%) 91 (65.9%) 20 (57.1%) 24 (75.0%) 4 (80.0%) 11 (57.9%)        0.649 
PAPR 39 (15.5%) 2 (8.7%) 25 (18.1%) 4 (11.4%) 5 (15.6%) 1 (20.0%) 2 (10.5%)        0.809 
N95 193 (76.6%) 14 (60.9%) 105 (76.1%) 24 (68.6%) 29 (90.6%) 2 (40.0%) 19 (100.0%)        0.001 
None 7 (2.8%) 3 (13.0%) 4 (2.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)        0.123 
Gloves 242 (96.0%) 21 (91.3%) 134 (97.1%) 31 (88.6%) 32 (100.0%) 5 (100.0%) 19 (100.0%)        0.109 
Gown 232 (92.1%) 21 (91.3%) 127 (92.0%) 29 (82.9%) 32 (100.0%) 5 (100.0%) 18 (94.7%)        0.190 
Goggles 211 (83.7%) 18 (78.3%) 116 (84.1%) 29 (82.9%) 28 (87.5%) 4 (80.0%) 16 (84.2%)        0.933 
How often used? (in %) 
     Mean ± SD 
     Median (IQR) 
 
  
94.8 ± 17.9 
100.0 (100.0, 100.0) 
 
  
94.9 ± 18.7 
100.0 (100.0, 100.0) 
 
  
93.0 ± 21.5 
100.0 (100.0, 100.
0) 
 
  
95.4 ± 17.2 
100.0 (100.0, 1
00.0) 
 
  
98.4 ± 5.0 
100.0 (100.0, 1
00.0) 
 
  
100.0 ± 0.0 
100.0 (100.0, 100
.0) 
 
  
98.2 ± 5.1 
100.0 (100.0, 
100.0) 
 
       0.763 K 
Table 1: Characteristics of Endoscopy Units that participated in the survey based on Continents 
 
 
Did any of your endoscopy staff have   
COVID infection? 
34 (13.5%) 2 (8.7%) 10 (7.2%) 17 (48.6%) 3 (9.4%) 0 (0.0%) 2 (10.5%)      < 0.001 
If any of your endoscopy staff had COVID
 infection, what % needed hospitalization 
     Mean ± SD 
     Median (IQR) 
 
  
7.9 ± 23.8 
0.0 (0.0, 2.0) 
 
  
100.0 ± 0.0 
100.0 (100.0, 100.0) 
 
  
1.0 ± 1.6 
0.0 (0.0, 2.0) 
 
  
2.8 ± 5.5 
0.0 (0.0, 0.0) 
 
  
0.0 ± 0.0 
0.0 (0.0, 0.0) 
  
 ± 
 (, ) 
 
  
5.0 ± 7.1 
5.0 (0.0, 10.0) 
 
       0.049 K 
Continuous variables compared using one-way analysis of variance. 
Categorical variables compared using chi-square or Fisher's exact test. 
(Except as noted: 
     K = Kruskal-Wallis test) 
 
Table 2: Characteristics of participating endoscopy units based on baseline total number of procedures performed 
 
 
 
  
Total Volume of procedures performed in a year 
     P-Value n = 252 
Tertile 1 (< 2499
) 
n = 74 
Tertile 2 (2500 t
o 6999) 
n = 93 
Tertile 3 (7000 to 1500
00) 
n = 85 
continent 
     AFRICA 
     ASIA 
     EUROPE 
     NORTHAM 
     OCEANIA 
     SOUTHAM 
  
23 (9.1%) 
138 (54.8%) 
35 (13.9%) 
32 (12.7%) 
5 (2.0%) 
19 (7.5%) 
  
12 (16.2%) 
44 (59.5%) 
4 (5.4%) 
9 (12.2%) 
0 (0.0%) 
5 (6.8%) 
  
10 (10.8%) 
45 (48.4%) 
11 (11.8%) 
12 (12.9%) 
4 (4.3%) 
11 (11.8%) 
  
1 (1.2%) 
49 (57.6%) 
20 (23.5%) 
11 (12.9%) 
1 (1.2%) 
3 (3.5%) 
       0.001 
Volume of procedures performed in you
r center in a year 
     Mean ± SD 
     Median (IQR) 
     Sum 
  
8212.1 ± 1513
3.2 
5000.0 (2000.
0, 9000.0) 
2069447 
  
1092.0 ± 635.9 
1000.0 (600.0, 1
500.0) 
80806.0 
  
4253.2 ± 1233.8 
4000.0 (3000.0,
 5000.0) 
395550.0 
  
18742.2 ± 22540.5 
12000.0 (9000.0, 2000
0.0) 
1593091 
     < 0.001 K 
Volume of procedures performed during 
COVID 
     Mean ± SD 
     Median (IQR) 
     Sum 
  
1833.7 ± 8166
.5 
500.0 (125.0, 
1500.0) 
462086.7 
  
206.3 ± 304.0 
102.5 (25.0, 240
.0) 
15263.1 
  
665.1 ± 872.1 
400.0 (150.0, 7
50.0) 
61850.5 
  
4529.1 ± 13681.1 
1875.0 (900.0, 3600.0) 
384973.1 
     < 0.001 K 
Total number of endoscopists in your un
it 
     Mean ± SD 
     Median (IQR) 
  
11.0 ± 14.4 
7.0 (3.0, 13.0) 
  
8.0 ± 18.2 
3.0 (2.0, 8.0) 
  
8.3 ± 7.6 
6.0 (4.0, 10.0) 
  
16.5 ± 15.0 
12.0 (8.0, 20.0) 
     < 0.001 K 
Total number of endoscopy nurses in yo
ur unit 
     Mean ± SD 
     Median (IQR) 
  
11.8 ± 14.8 
6.5 (3.0, 15.0) 
  
5.1 ± 6.9 
3.0 (2.0, 6.0) 
  
9.4 ± 11.0 
6.0 (3.0, 11.0) 
  
20.2 ± 19.0 
16.0 (8.0, 25.0) 
     < 0.001 K 
Total number of endoscopy technicians 
in your unit 
     Mean ± SD 
     Median (IQR) 
  
5.2 ± 7.8 
3.0 (1.0, 6.0) 
  
3.3 ± 6.2 
2.0 (1.0, 3.0) 
  
3.6 ± 2.9 
3.0 (2.0, 5.0) 
  
8.5 ± 11.1 
5.0 (3.0, 10.0) 
     < 0.001 K 
Table 2: Characteristics of participating endoscopy units based on baseline total number of procedures performed 
 
 
 
  
Total Volume of procedures performed in a year 
     P-Value n = 252 
Tertile 1 (< 2499
) 
n = 74 
Tertile 2 (2500 t
o 6999) 
n = 93 
Tertile 3 (7000 to 1500
00) 
n = 85 
% of procedures performed in your cent
er since COVID infection in your region 
compared to baseline 
     Mean ± SD 
     Median (IQR) 
  
17.1 ± 17.6 
10.0 (5.0, 20.0
) 
  
17.9 ± 19.7 
10.0 (5.0, 25.0) 
  
14.7 ± 16.4 
10.0 (5.0, 20.0) 
  
19.0 ± 16.9 
15.0 (7.0, 25.0) 
       0.048 K 
% of EGD/EUS/ERCP procedures durin
g COVID compared to baseline 
     Mean ± SD 
     Median (IQR) 
  
18.8 ± 20.7 
10.0 (5.0, 25.0
) 
  
16.2 ± 21.2 
10.0 (2.0, 20.0) 
  
16.9 ± 20.2 
10.0 (3.0, 20.0) 
  
23.0 ± 20.4 
19.0 (10.0, 30.0) 
     < 0.001 K 
%  of colonoscopy/sigmoidoscopy proce
dures performed during COVID compar
ed to baseline 
     Mean ± SD 
     Median (IQR) 
  
15.2 ± 18.9 
10.0 (3.0, 20.0
) 
  
15.8 ± 20.6 
8.5 (2.0, 20.0) 
  
12.8 ± 17.2 
5.0 (2.0, 15.0) 
  
17.3 ± 19.2 
10.0 (5.0, 20.0) 
       0.033 K 
PPE for colonoscopy/sigmoidoscopy      
Face Mask/surgical mask 182 (72.2%) 50 (67.6%) 72 (77.4%) 60 (70.6%)        0.338 
PAPR 36 (14.3%) 10 (13.5%) 14 (15.1%) 12 (14.1%)        0.959 
N95 167 (66.3%) 49 (66.2%) 61 (65.6%) 57 (67.1%)        0.978 
None 5 (2.0%) 3 (4.1%) 2 (2.2%) 0 (0.0%)        0.231 
Gloves 242 (96.0%) 70 (94.6%) 90 (96.8%) 82 (96.5%)        0.782 
Gown 230 (91.3%) 66 (89.2%) 83 (89.2%) 81 (95.3%)        0.271 
Goggles 194 (77.0%) 51 (68.9%) 77 (82.8%) 66 (77.6%)        0.104 
How often used? ( in %) 
     Mean ± SD 
     Median (IQR) 
     Missing 
  
92.9 ± 20.7 
100.0 (100.0, 
100.0) 
79 
  
89.3 ± 27.9 
100.0 (99.0, 100
.0) 
23 
  
93.5 ± 19.4 
100.0 (100.0, 1
00.0) 
28 
  
95.4 ± 13.2 
100.0 (100.0, 100.0) 
28 
       0.832 K 
PPE for upper endoscopy – 
EGD/EUS/ERCP 
     
Face Mask/surgical mask 166 (65.9%) 46 (62.2%) 66 (71.0%) 54 (63.5%)        0.420 
PAPR 39 (15.5%) 12 (16.2%) 15 (16.1%) 12 (14.1%)        0.913 
Table 2: Characteristics of participating endoscopy units based on baseline total number of procedures performed 
 
 
 
  
Total Volume of procedures performed in a year 
     P-Value n = 252 
Tertile 1 (< 2499
) 
n = 74 
Tertile 2 (2500 t
o 6999) 
n = 93 
Tertile 3 (7000 to 1500
00) 
n = 85 
N95 193 (76.6%) 57 (77.0%) 69 (74.2%) 67 (78.8%)        0.762 
None 7 (2.8%) 4 (5.4%) 2 (2.2%) 1 (1.2%)        0.300 
Gloves 242 (96.0%) 70 (94.6%) 90 (96.8%) 82 (96.5%)        0.782 
Gown 232 (92.1%) 67 (90.5%) 85 (91.4%) 80 (94.1%)        0.676 
Goggles 211 (83.7%) 61 (82.4%) 81 (87.1%) 69 (81.2%)        0.529 
How often used? (in %) 
     Mean ± SD 
     Median (IQR) 
     Missing 
  
94.8 ± 17.9 
100.0 (100.0, 
100.0) 
54 
  
92.0 ± 26.1 
100.0 (100.0, 10
0.0) 
16 
  
95.7 ± 14.6 
100.0 (100.0, 1
00.0) 
20 
  
96.4 ± 11.4 
100.0 (100.0, 100.0) 
18 
       0.880 K 
Did any of your endoscopy staff have C
OVID infection? 
34 (13.5%) 2 (2.7%) 9 (9.7%) 23 (27.1%)      < 0.001 
If any of your endoscopy staff had COVI
D infection, what % needed hospitalizati
on 
     Mean ± SD 
     Median (IQR) 
     Missing 
  
7.9 ± 23.8 
0.0 (0.0, 2.0) 
218 
  
0.0 ± 0.0 
0.0 (0.0, 0.0) 
72 
  
14.4 ± 32.7 
0.0 (0.0, 15.0) 
84 
  
6.0 ± 20.7 
0.0 (0.0, 2.0) 
62 
       0.582 K 
Continuous variables compared using one-way analysis of variance. 
Categorical variables compared using chi-square or Fisher's exact test. 
(Except as noted: 
     K = Kruskal-Wallis test) 
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Figure 1e: Endoscopy units’ survey respondents' 
distribution  according to geographic location 
(ArcGIS image).
